Isotoxic Intensity Modulated Radiation Therapy in Stage III Non-Small Cell Lung Cancer: A Feasibility Study

PURPOSE: Not all patients with stage III non-small cell lung cancer (NSCLC) are suitable for concurrent chemoradiation therapy (CRT). Local failure rate is high for sequential concurrent CRT. As such, there is a rationale for treatment intensification. METHODS AND MATERIALS: Isotoxic intensity modul...

Descripción completa

Detalles Bibliográficos
Autores principales: Haslett, Kate, Bayman, Neil, Franks, Kevin, Groom, Nicki, Harden, Susan V., Harris, Catherine, Hanna, Gerard, Harrow, Stephen, Hatton, Matthew, McCloskey, Paula, McDonald, Fiona, Ryder, W. David, Faivre-Finn, Corinne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier, Inc 2021
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955281/
https://www.ncbi.nlm.nih.gov/pubmed/33232772
http://dx.doi.org/10.1016/j.ijrobp.2020.11.040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955281/
https://www.ncbi.nlm.nih.gov/pubmed/33232772
http://dx.doi.org/10.1016/j.ijrobp.2020.11.040

Ejemplares similares